The trial was terminated prematurely due to an observed trend toward futility for efficacy combined with expected safety concerns, which weakens the putative causal association of short episodes of AF with ESUS. 36 Should We Screen All Patients With ESUS for AF?
← all excerpts
Risk Stratification Tools to Guide a Personalized Approach for Cardiac Monitoring in Embolic Stroke of Undetermined Source.
1
—
—